首页工具

搜索结果

Search Results for " mln 2238 "

如果没找到您满意的产品或者您对产品有其他要求，可以联系我们专业顾问为您提供针对性的合理建议。 QQ咨询网站留言咨询

Cat. No.	Product Name	Target	Signaling Pathways
T2122	Ixazomib 艾沙佐米,MLN2238	Proteasome; Caspase; Autophagy	Apoptosis; Autophagy; Proteases/Proteasome; Ubiquitination
	Ixazomib (MLN2238) 含硼肽蛋白酶体抑制剂(PI)，可抑制 20S 蛋白酶体的糜蛋白酶样蛋白水解 (β5) 位点，IC50为 3.4 nM，Ki 为 0.93 nM。它还抑制半胱天冬酶样 (β1) 和胰蛋白酶样 (β2) 蛋白水解位点，IC50值为 31和3500 nM。
T69983	Ixazomib citrate EtOH
	Ixazomib citrate, also known as MLN9708, is a prodrug of Ixazomib (MMLN-2238). MLN9708 is an orally bioavailable second generation proteasome inhibitor (PI) with potential antineoplastic activity. MLN9708, after hydrolyzing to pharmacologically active MLN2238 (ixazomib), is a next-generation proteasome inhibitor with demonstrated preclinical and clinical antimyeloma activity. MLN9708, compared with bortezomib, has improved pharmacokinetics, pharmacodynamics, and antitumor activity in preclinic...
T8397	Ixazomib citrate 枸橼酸艾沙佐米,MLN9708	Proteasome; Autophagy	Autophagy; Proteases/Proteasome; Ubiquitination
	Ixazomib citrate (MLN9708) 是 Ixazomib 的前药，是20S 蛋白酶体胰凝乳蛋白酶样蛋白水解β5位点的可逆抑制剂，IC50为3.4 nM 和Ki 为0.93 nM。